Literature DB >> 15365918

Predictors of inotrope use during separation from cardiopulmonary bypass.

Kenneth H McKinlay1, David B Schinderle, Madhav Swaminathan, Mihai V Podgoreanu, Carmelo A Milano, Robert H Messier, Habib El-Moalem, Mark F Newman, Fiona M Clements, Joseph P Mathew.   

Abstract

OBJECTIVE: To identify the demographic, clinical, and echocardiographic features that predict the use of inotropic support at separation from cardiopulmonary bypass (CPB).
DESIGN: Retrospective study of consecutive patients undergoing coronary artery bypass graft (CABG) surgery.
SETTING: Referral center for cardiothoracic surgery at a university hospital. PARTICIPANTS: One thousand nine patients undergoing either CABG or combined CABG and valve surgery with CPB in whom an intraoperative transesophageal echocardiography (TEE) examination was performed.
INTERVENTIONS: Inotropic support was defined as the use of dopamine >/=5 microg/kg/min; any dose of epinephrine, norepinephrine, dobutamine, and milrinone; or the insertion of an IABP during separation from CPB. Support was implemented by the anesthesia care team as clinically indicated. Comprehensive TEE examinations were conducted before CPB in all patients according to published guidelines and subsequently reviewed by a single, independent operator.
MEASUREMENTS AND MAIN RESULTS: Inotropic support was used in a total of 394 patients (39%) at separation from CPB. The study identified 6 significant, independent predictors of inotrope use: (1) Wall Motion Score Index, (2) combined CABG and mitral valve repair or replacement surgery, (3) left ventricular ejection fraction <35%, (4) reoperation, (5) moderate-to-severe mitral regurgitation, and (6) aortic cross-clamp time.
CONCLUSIONS: Incorporating data from a comprehensive intraoperative TEE examination, the authors identified 6 reproducible factors that independently predict the use of inotropic support at separation from CPB.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15365918     DOI: 10.1053/j.jvca.2004.05.015

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  8 in total

Review 1.  [Cardiopulmonary bypass in cardiac surgery].

Authors:  T Baehner; O Boehm; C Probst; B Poetzsch; A Hoeft; G Baumgarten; P Knuefermann
Journal:  Anaesthesist       Date:  2012-10       Impact factor: 1.041

2.  Evaluation and optimisation of current milrinone prescribing for the treatment and prevention of low cardiac output syndrome in paediatric patients after open heart surgery using a physiology-based pharmacokinetic drug-disease model.

Authors:  Winnie Vogt
Journal:  Clin Pharmacokinet       Date:  2014-01       Impact factor: 6.447

3.  Preoperative diastolic function predicts the onset of left ventricular dysfunction following aortic valve replacement in high-risk patients with aortic stenosis.

Authors:  Marc Licker; Mustafa Cikirikcioglu; Cidgem Inan; Vanessa Cartier; Afksendyios Kalangos; Thomas Theologou; Tiziano Cassina; John Diaper
Journal:  Crit Care       Date:  2010-06-03       Impact factor: 9.097

4.  Vasoactive-inotropic score as a predictor of morbidity and mortality in adults after cardiac surgery with cardiopulmonary bypass.

Authors:  Yumiko Yamazaki; Koji Oba; Yoshiro Matsui; Yuji Morimoto
Journal:  J Anesth       Date:  2018-01-13       Impact factor: 2.078

5.  On-Pump Beating/Non-Beating CABG in Stable Angina Have Similar Outcomes.

Authors:  Victor Dayan; Juan Jose Paganini; Alvaro Marichal; Daniel Brusich
Journal:  Braz J Cardiovasc Surg       Date:  2018 Mar-Apr

6.  Predictors of inotrope use in patients undergoing concomitant coronary artery bypass graft (CABG) and aortic valve replacement (AVR) surgeries at separation from cardiopulmonary bypass (CPB).

Authors:  Imdad Ahmed; Chad M House; William B Nelson
Journal:  J Cardiothorac Surg       Date:  2009-06-12       Impact factor: 1.637

7.  Use of Vasoactive Medications after Cardiac Surgery in the United States.

Authors:  Emily A Vail; Meng-Shiou Shieh; Penelope S Pekow; Hayley B Gershengorn; Allan J Walkey; Peter K Lindenauer; Hannah Wunsch
Journal:  Ann Am Thorac Soc       Date:  2021-01

8.  In patients chronically treated with metoprolol, the demand of inotropic catecholamine support after coronary artery bypass grafting is determined by the Arg389Gly-beta 1-adrenoceptor polymorphism.

Authors:  Kirsten Leineweber; Petra Bogedain; Christina Wolf; Sören Wagner; Melanie Weber; Heinz-Günther Jakob; Gerd Heusch; Thomas Philipp; Otto-Erich Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-06-01       Impact factor: 3.195

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.